Abivax S.A. (ABVX)

R&D Expenses

€180.68M

TTM · Period ending: · EUR

ABVX logo

ABVX R&D Expenses

Latest reported€180.68M EUR
ABVX TTM R&D Expenses · EUR (€19.03M → €180.68M)
High-resolution chart · PNG

ABVX r&d expenses history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Abivax S.A. R&D Expenses — Trailing twelve months (TTM) (EUR)
Period endingR&D Expenses (EUR)
180,680,000
151,252,000
177,407,000
171,384,000
164,922,000
151,122,000
103,815,000
95,148,000
83,367,000
81,728,000
72,507,000
63,533,000
51,282,000
44,875,000
35,966,000
26,714,000
24,161,000
26,305,000
29,496,000
30,726,000
28,236,000
19,031,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.